Evidence map›Paper›PMID 33521474›Full record

ArticleACS omega2021

Exploring the Active Components of Simotang Oral Liquid and Their Potential Mechanism of Action on Gastrointestinal Disorders by Integrating Ultrahigh-Pressure Liquid Chromatography Coupled with Linear Ion Trap-Orbitrap Analysis and Network Pharmacology.

Zhiqiang Luo, Guohua Yu, Xing Han, Yang Liu, Guopeng Wang, Xueyan Li, Haiyang Yang, Wenyan Sun

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Exploring dynamic changes in metabolic profiles ofFrontiers in plant science · 2026
    Article
  3. Article
  4. Analysis of composition of gut microbial community in a rat model of functional dyspepsia treated with Simo Tang.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Integrated Strategy FromFrontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhiqiang LuoSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing 102488, China.
Guohua YuSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing 102488, China.
Xing HanSchool of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Yang LiuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Guopeng WangZhongcai Health (Beijing) Biological Technology Development Co., Ltd., Beijing 101500, China.
Xueyan LiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Haiyang YangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Wenyan SunSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Beijing University of Chinese Medicine · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Simotang oral liquid (SMT), a well-known traditional Chinese medicine formula composed of four medicinal and edible plants, has been extensively used for treating gastrointestinal disorders (GIDs) since ancient times. However, the major active constituents and the underlying molecular mechanism of SMT on GIDs are still partially understood. Herein, the preliminary chemical profile of SMT was first identified by ultrahigh-pressure liquid chromatography coupled with linear ion trap-Orbitrap tandem mass spectrometry (UHPLC-LTQ-Orbitrap). In total, 70 components were identified. Then, a network pharmacology approach integrating target prediction, pathway enrichment analysis, and network construction was adopted to explore the therapeutic mechanism of SMT. As a result, 170 main targets were screened out and considered as effective players in ameliorating GIDs. More importantly, the major hubs were found to be highly enriched in a calcium signaling pathway. Furthermore, 26 core SMT-related genes were identified, which may play key roles in ameliorating gastrointestinal motility. In conclusion, this work would provide valuable information for further development and clinical application of SMT.

Identifiers

PMID33521474
PMCPMC7841926
OpenAlexW3119672068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.